Terms: = Liver cancer AND CASP8, ALPS2B, 841, ENSG00000064012, MGC78473, CAP4, MACH, MCH5, FLICE
265 results:
1. Association between treatment-emergent hypertension and survival with lenvatinib treatment for patients with hepatocellular carcinoma in the REFLECT study.
Piscaglia F; Ikeda K; Cheng AL; Kudo M; Ikeda M; Breder V; Ryoo BY; Mody K; Ren M; Ramji Z; Sung MW
Cancer; 2024 Apr; 130(8):1281-1291. PubMed ID: 38261521
[TBL] [Abstract] [Full Text] [Related]
2. Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma.
Camera S; Rimini M; Rossari F; Tada T; Suda G; Shimose S; Kudo M; Yoo C; Cheon J; Finkelmeier F; Lim HY; Presa J; Masi G; Bergamo F; Salani F; Marseglia M; Amadeo E; Vitiello F; Kumada T; Sakamoto N; Iwamoto H; Aoki T; Chon HJ; Himmelsbach V; Iavarone M; Cabibbo G; Montes M; Foschi FG; Vivaldi C; Lonardi S; Sho T; Niizeki T; Nishida N; Steup C; Hirooka M; Kariyama K; Tani J; Atsukawa M; Takaguchi K; Itobayashi E; Fukunishi S; Tsuji K; Ishikawa T; Tajiri K; Ochi H; Yasuda S; Toyoda H; Ogawa C; Nishimura T; Hatanaka T; Kakizaki S; Shimada N; Kawata K; Hiraoka A; Tada F; Ohama H; Nouso K; Morishita A; Tsutsui A; Nagano T; Itokawa N; Okubo T; Imai M; Kosaka H; Naganuma A; Koizumi Y; Nakamura S; Kaibori M; Iijima H; Hiasa Y; Persano M; Foti S; Piscaglia F; Scartozzi M; Cascinu S; Casadei-Gardini A
Target Oncol; 2024 Jan; 19(1):29-39. PubMed ID: 38252195
[TBL] [Abstract] [Full Text] [Related]
3. [Hepatitis B virus infection status and clinical characteristics in patients with rheumatoid arthritis].
Zheng HW; Ouyang ZM; Pan J; Jia PW; Zou YW; Ma JD; Chen LF; Li QH; Wu T; Dai L
Zhonghua Yi Xue Za Zhi; 2024 Jan; 104(3):205-211. PubMed ID: 38220446
[No Abstract] [Full Text] [Related]
4. Performance of non-invasive tests for liver fibrosis resolution after bariatric surgery.
Raverdy V; Tavaglione F; Chatelain E; Caiazzo R; Saponaro C; Lassailly G; Verkindt H; Baud G; Marciniak C; Chetboun M; Oukhouya-Daoud N; Gnemmi V; Leteurtre E; Duhamel A; Philippe M; Marot G; Romeo S; Pattou F
Metabolism; 2024 Apr; 153():155790. PubMed ID: 38219973
[TBL] [Abstract] [Full Text] [Related]
5. Multidimensional Analysis of PANoptosis-Related Molecule casp8: Prognostic Significance, Immune Microenvironment Effect, and Therapeutic Implications in Hepatocellular Carcinoma.
Peng F; Zhu F; Cao B; Peng L
Genet Res (Camb); 2023; 2023():2406193. PubMed ID: 38186679
[TBL] [Abstract] [Full Text] [Related]
6. Novel urine cell-free DNA methylation markers for hepatocellular carcinoma.
Lin SY; Xia W; Kim AK; Chen D; Schleyer S; Choi L; Wang Z; Hamilton JP; Luu H; Hann HW; Chang TT; Hu CT; Woodard A; Gade TP; Su YH
Sci Rep; 2023 Dec; 13(1):21585. PubMed ID: 38062093
[TBL] [Abstract] [Full Text] [Related]
7. Prediction of preoperative microvascular invasion by dynamic radiomic analysis based on contrast-enhanced computed tomography.
Zhou Z; Xia T; Zhang T; Du M; Zhong J; Huang Y; Xuan K; Xu G; Wan Z; Ju S; Xu J
Abdom Radiol (NY); 2024 Feb; 49(2):611-624. PubMed ID: 38051358
[TBL] [Abstract] [Full Text] [Related]
8. Significance of chemotherapy for older patients with nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A propensity score matching analysis.
Chen J; Ding J; Xu Y; Hong H; Lin X; Xu M; Yan L; Xu T; Fei Z; Chen C
J Geriatr Oncol; 2023 Nov; 14(8):101648. PubMed ID: 37897887
[TBL] [Abstract] [Full Text] [Related]
9. MRI-based radiomics signature: a potential imaging biomarker for prediction of microvascular invasion in combined hepatocellular-cholangiocarcinoma.
Zhou G; Zhou Y; Xu X; Zhang J; Xu C; Xu P; Zhu F
Abdom Radiol (NY); 2024 Jan; 49(1):49-59. PubMed ID: 37831165
[TBL] [Abstract] [Full Text] [Related]
10. Doxorubicin-loaded Niosomes functionalized with gelatine and alginate as pH-responsive drug delivery system: A 3D printing approach.
Zaer M; Moeinzadeh A; Abolhassani H; Rostami N; Tavakkoli Yaraki M; Seyedi SA; Nabipoorashrafi SA; Bashiri Z; Moeinabadi-Bidgoli K; Moradbeygi F; Farmani AR; Hossein-Khannazer N
Int J Biol Macromol; 2023 Dec; 253(Pt 2):126808. PubMed ID: 37689301
[TBL] [Abstract] [Full Text] [Related]
11. Survival Benefit Relative to Treatment Modalities Among Patients with Very Early Intrahepatic Cholangiocarcinoma: an Analysis of the National cancer Database.
Endo Y; Sasaki K; Munir MM; Woldesenbet S; Resende V; Rawicz-PruszyĆski K; Waqar U; Mavani P; Katayama E; Yang J; Khalil M; Khan MMM; Kitago M; Pawlik TM
J Gastrointest Surg; 2023 Oct; 27(10):2103-2113. PubMed ID: 37674099
[TBL] [Abstract] [Full Text] [Related]
12. Feasibility of acquisitions using total-body PET/CT with a half-dose [
Chen Z; Wang Y; Yang X; Li L; Huo Y; Yu X; Xiao X; Zhang C; Chen Y; Zhao H; Zhou Y; Huang G; Liu J; Chen R
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3961-3969. PubMed ID: 37535107
[TBL] [Abstract] [Full Text] [Related]
13. Long-Term Survival, Prognostic Factors, and Selection of Patients With Colorectal cancer for liver Transplant: A Nonrandomized Controlled Trial.
Dueland S; Smedman TM; Syversveen T; Grut H; Hagness M; Line PD
JAMA Surg; 2023 Sep; 158(9):e232932. PubMed ID: 37494056
[TBL] [Abstract] [Full Text] [Related]
14. Association between daily aspirin therapy and risk of hepatocellular carcinoma according to metabolic risk factor burden in non-cirrhotic patients with chronic hepatitis B.
Lee CH; Lee YB; Moon H; Chung JW; Cho EJ; Lee JH; Yu SJ; Kim YJ; Lee J; Yoon JH
Aliment Pharmacol Ther; 2023 Oct; 58(7):704-714. PubMed ID: 37461332
[TBL] [Abstract] [Full Text] [Related]
15. MRI-Based Radiomics Nomogram for Preoperatively Differentiating Intrahepatic Mass-Forming Cholangiocarcinoma From Resectable Colorectal liver Metastases.
Xu Y; Ye F; Li L; Yang Y; Ouyang J; Zhou Y; Wang S; Xie L; Zhou J; Zhao H; Zhao X
Acad Radiol; 2023 Sep; 30(9):2010-2020. PubMed ID: 37414635
[TBL] [Abstract] [Full Text] [Related]
16. [Construction of a prognostic model for hepatocellular carcinoma based on pyroptosis-related genes].
Rong HC; Zhao WF; Zheng N; Guo ZH; Wang YW; Huang XP
Zhonghua Gan Zang Bing Za Zhi; 2023 May; 31(5):509-517. PubMed ID: 37365028
[No Abstract] [Full Text] [Related]
17. First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal cancer Group.
Bond MJG; Bolhuis K; Loosveld OJL; de Groot JWB; Droogendijk H; Helgason HH; Hendriks MP; Klaase JM; Kazemier G; Liem MSL; Rijken AM; Verhoef C; de Wilt JHW; de Jong KP; Gerhards MF; van Amerongen MJ; Engelbrecht MRW; van Lienden KP; Molenaar IQ; de Valk B; Haberkorn BCM; Kerver ED; Erdkamp F; van Alphen RJ; Mathijssen-van Stein D; Komurcu A; Lopez-Yurda M; Swijnenburg RJ; Punt CJA;
Lancet Oncol; 2023 Jul; 24(7):757-771. PubMed ID: 37329889
[TBL] [Abstract] [Full Text] [Related]
18. Global uses of traditional herbs for hepatic diseases and other pharmacological actions: A comprehensive review.
Choudhary A; Noman M; Bano U; Akhtar J; Shaikh Y; Yar MS
Polim Med; 2023; 53(1):81-89. PubMed ID: 37260126
[TBL] [Abstract] [Full Text] [Related]
19. A nomogram for predicting cause-specific mortality among patients with cecal carcinoma: a study based on SEER database.
Zhou Q; Zhan Y; Guo J
BMC Gastroenterol; 2023 May; 23(1):177. PubMed ID: 37221487
[TBL] [Abstract] [Full Text] [Related]
20. Discrimination of liver Metastases of Digestive System Neuroendocrine Tumors From Neuroendocrine Carcinoma by Computed Tomography-Based Radiomics Analysis.
Gu XL; Cui Y; Zhu HT; Li XT; Pei X; He XX; Yang L; Lu M; Li ZW; Sun YS
J Comput Assist Tomogr; 2023 May-Jun 01; 47(3):361-368. PubMed ID: 37184997
[TBL] [Abstract] [Full Text] [Related]
[Next]